Precigen (PGEN) Current Deferred Revenue (2016 - 2025)
Historic Current Deferred Revenue for Precigen (PGEN) over the last 14 years, with Q3 2025 value amounting to $575000.0.
- Precigen's Current Deferred Revenue fell 7642.48% to $575000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $575000.0, marking a year-over-year decrease of 7642.48%. This contributed to the annual value of $2.5 million for FY2024, which is 842.29% up from last year.
- According to the latest figures from Q3 2025, Precigen's Current Deferred Revenue is $575000.0, which was down 7642.48% from $2.2 million recorded in Q2 2025.
- In the past 5 years, Precigen's Current Deferred Revenue registered a high of $26.9 million during Q1 2021, and its lowest value of $15000.0 during Q2 2023.
- Moreover, its 5-year median value for Current Deferred Revenue was $2.3 million (2023), whereas its average is $9.3 million.
- As far as peak fluctuations go, Precigen's Current Deferred Revenue crashed by 9993.53% in 2023, and later skyrocketed by 1454000.0% in 2024.
- Quarter analysis of 5 years shows Precigen's Current Deferred Revenue stood at $24.5 million in 2021, then plummeted by 92.48% to $1.8 million in 2022, then rose by 26.26% to $2.3 million in 2023, then increased by 8.42% to $2.5 million in 2024, then plummeted by 77.21% to $575000.0 in 2025.
- Its last three reported values are $575000.0 in Q3 2025, $2.2 million for Q2 2025, and $2.4 million during Q1 2025.